Value-Based Health Care & Specialty Pharmacy - PPN Episode 861

Christopher Kennedy, Chief Operating Officer at Heritage Biologics, Inc., interviews Dr. Mahek A. Shah. about the importance of understanding what Value-Based Health Care truly is & how Specialty Pharmacy dove tails with the transformation of healthcare services to the coming of a new age of patient focus.  About our guest Mahek A. Shah, M.D. Senior Researcher at Harvard Business School.  Mahek A. Shah, MD is a Senior Project Leader and Senior Researcher at Harvard Business School. Dr. Shah leads Harvard Business School’s Value Measurement for Health Care projects, implementing time-driven activity-based costing (TDABC) globally to understand real and actual costs of care delivery. Shah teaches and advises executives at large health systems, governments, and companies on how to better understand and measure their outcomes and costs. Working with Professors Bob Kaplan and Michael Porter, he designs and advises the implementation of the new framework for restructuring health care systems around the world, Value-Based Health Care, with the overarching goal of delivering more value for the patient: better outcomes at lower costs. Dr. Shah is the co-author of two Harvard Business School (HBS) case studies. He has been published in the Journal of the American Medical Association (JAMA), World Health Organization (WHO), and Forbes. Shah delivered a TED talk at Harvard: Bringing Patient-centered Design to Healthcare. For more than 10 years, Dr. Shah has focused on redesigning health care to improve patient outcomes, leverage technology, and the health care experience. His methodologies emphasize maximizing value through measurement, aligning the provider and payers, and utilizing real-time data to drive decision making. Dr. Shah speaks globally on the future of health care delivery, measurement, alternative payment models, and the business of healthcare. Dr. Shah advises the World Economic Forum, the US Department of Health and Human Services (HHS), and serves on the New England Journal of Medicine’s Catalyst Insights Council. Prior to medicine, Dr. Shah worked on Wall Street at Citigroup. Follow and engage with him on twitter at @Mahek_MD See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices